CIGB

Monday, February 09, 2026

NEWS

CECMED authorizes to use phase-II trial with CIGB2020 candidate

Published on: August 12, 2021
07:36

Havana, Aug 12 (Prensa Latina) Cuba´s Center for State Control of medicines, Equipment and Medical Devices (CECMED) on Wednesday authorized the start of a phase-II clinical trial with the vaccine candidate CIGB2020, seeking to stimulate the immune response against acute respiratory infections.

CIGB, 35 years of history written with scientific innovation

Published on: July 1, 2021
09:01

Havana, Jul 1 (Prensa Latina) The fundamental characteristic of the CIGB, which marks 35 years this Thursday, lies in its new products, Dr. Gerardo Guillen, Director of Biomedical Research, told exclusively Prensa Latina.

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

Radio – Publications – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado, Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division Prensa Latina.

CIGB

CECMED authorizes to use phase-II trial with CIGB2020 candidate

CIGB, 35 years of history written with scientific innovation

LATEST NEWS